SG11201407924RA - METHOD OF TREATING <i>SCEDOSPORIUM SPP</i>. INFECTION - Google Patents
METHOD OF TREATING <i>SCEDOSPORIUM SPP</i>. INFECTIONInfo
- Publication number
- SG11201407924RA SG11201407924RA SG11201407924RA SG11201407924RA SG11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA SG 11201407924R A SG11201407924R A SG 11201407924RA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- infection
- new south
- south wales
- scedosporium spp
- Prior art date
Links
- 241000132889 Scedosporium Species 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012902243A AU2012902243A0 (en) | 2012-05-30 | Method of treating Seedosporium spp. infection | |
| PCT/AU2013/000487 WO2013177608A1 (en) | 2012-05-30 | 2013-05-13 | Method of treating scedosporium spp. infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407924RA true SG11201407924RA (en) | 2014-12-30 |
Family
ID=49672167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407924RA SG11201407924RA (en) | 2012-05-30 | 2013-05-13 | METHOD OF TREATING <i>SCEDOSPORIUM SPP</i>. INFECTION |
Country Status (9)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111194213A (zh) * | 2017-08-01 | 2020-05-22 | 澳宝生物科学有限公司 | 使用取代的硝基苯乙烯化合物治疗葡萄球菌和肠球菌感染 |
| BR112022022409A2 (pt) | 2020-05-06 | 2023-02-07 | Ajax Therapeutics Inc | 6-heteroarilóxi benzimidazóis e azabenzimidazóis como inibidores de jak2 |
| US12043632B2 (en) | 2020-12-23 | 2024-07-23 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
| US11970494B2 (en) | 2021-11-09 | 2024-04-30 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
| WO2023086320A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985761A (en) * | 1974-10-24 | 1976-10-12 | Sarabhai Research Centre | Nitrothiazolyl derivatives of nitrostyrene |
| JPS585902B2 (ja) * | 1978-09-01 | 1983-02-02 | 株式会社大塚製薬工場 | β↓−ニトロスチレン誘導体 |
| RU2259825C9 (ru) * | 2001-06-18 | 2006-04-10 | БиоДием Лимитед | Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности |
| KR20080099230A (ko) * | 2005-10-24 | 2008-11-12 | 스타발 파마, 리미티드 | 진균 및 세균의 처리/방제/사멸 방법 |
| US20080220103A1 (en) * | 2005-10-24 | 2008-09-11 | Jay Birnbaum | Method for treating/controlling/killing fungi and bacteria on living animals |
| WO2008061308A1 (en) * | 2006-11-22 | 2008-05-29 | Biodiem Ltd | Protein tyrosine phosphatase modulators |
| CN102065851A (zh) * | 2008-04-25 | 2011-05-18 | 纳米生物公司 | 治疗真菌、酵母和霉菌感染的纳米乳剂 |
| UA107963C2 (xx) * | 2010-06-07 | 2015-03-10 | Janssen Pharmaceutica Nv | ПРОТИГРИБКОВІ ПОХІДНІ 5,6-ДИГІДРО-4-$(ДИФТОРЕТИЛ)ФЕНІЛ]-4H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНУ І 4-(ДИФТОРЕТИЛ)ФЕНІЛ-6H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНУ |
-
2013
- 2013-04-12 AU AU2013204604A patent/AU2013204604B2/en not_active Ceased
- 2013-05-13 WO PCT/AU2013/000487 patent/WO2013177608A1/en active Application Filing
- 2013-05-13 JP JP2015514283A patent/JP2015518007A/ja active Pending
- 2013-05-13 CA CA2874881A patent/CA2874881A1/en not_active Abandoned
- 2013-05-13 AU AU2013270430A patent/AU2013270430A1/en not_active Abandoned
- 2013-05-13 SG SG11201407924RA patent/SG11201407924RA/en unknown
- 2013-05-13 EP EP13798071.0A patent/EP2854799B1/en not_active Not-in-force
- 2013-05-13 US US14/404,851 patent/US9867802B2/en not_active Expired - Fee Related
- 2013-05-13 CN CN201380029050.6A patent/CN104519882A/zh active Pending
-
2014
- 2014-12-05 ZA ZA2014/08975A patent/ZA201408975B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1209052A1 (en) | 2016-03-24 |
| US9867802B2 (en) | 2018-01-16 |
| CA2874881A1 (en) | 2013-12-05 |
| AU2013204604A1 (en) | 2013-12-19 |
| JP2015518007A (ja) | 2015-06-25 |
| EP2854799A1 (en) | 2015-04-08 |
| EP2854799B1 (en) | 2018-04-25 |
| AU2013204604B2 (en) | 2016-05-19 |
| CN104519882A (zh) | 2015-04-15 |
| EP2854799A4 (en) | 2015-10-21 |
| AU2013270430A1 (en) | 2014-12-18 |
| WO2013177608A1 (en) | 2013-12-05 |
| ZA201408975B (en) | 2016-10-26 |
| US20150126436A1 (en) | 2015-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201901747VA (en) | Inhibitors of cellular metabolic processes | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201906386XA (en) | Combination therapy involving diaryl macrocyclic compounds | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201408133TA (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| SG11201803686UA (en) | Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease | |
| SG11201408094YA (en) | Neprilysin inhibitors | |
| SG11201407037UA (en) | Catechol o-methyltransferase activity inhibiting compounds | |
| SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| SG11201406787TA (en) | Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201407537YA (en) | Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer | |
| SG11201408261UA (en) | Syringe | |
| SG11201407900WA (en) | Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof | |
| SG11201407867VA (en) | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201407372UA (en) | Nampt inhibitors | |
| SG11201408383SA (en) | Methods of detecting diseases or conditions using circulating diseased cells | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201408685WA (en) | Antibacterial microelement chelates and the use thereof in animal feeds | |
| SG11201810974QA (en) | Methods and compositions for prostate cancer diagnosis and treatment | |
| SG11201407924RA (en) | METHOD OF TREATING <i>SCEDOSPORIUM SPP</i>. INFECTION | |
| SG11201805001UA (en) | Method of treating influenza a |